House of Lords Business
Show full summary

Lord Campbell-Savours to ask Her Majesty's Government what is the optimum gap between the first and second dose of (1) the Oxford/AstraZeneca, and (2) the Pfizer/BioNTech, COVID-19 vaccine for securing the longest period of protection against COVID-19.  HL11805

Question HL11805: tabled on 6 January 2021 and due for answer by 20 January 2021

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Campbell-Savours to ask Her Majesty's Government what is the optimum gap between the first and second dose of (1) the Oxford/AstraZeneca, and (2) the Pfizer/BioNTech, COVID-19 vaccine for securing the longest period of protection against COVID-19.  HL11805
Legend for business item text
† Item that is new or altered.
[I] Indicates that the member concerned has a relevant registered interest.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Campbell-Savours
Labour
Life peer